MARKET

TLPH

TLPH

Talphera Inc
NASDAQ
1.030
-0.040
-3.74%
After Hours: 1.030 0 0.00% 16:10 06/26 EDT
OPEN
1.070
PREV CLOSE
1.070
HIGH
1.070
LOW
0.9900
VOLUME
270.97K
TURNOVER
--
52 WEEK HIGH
1.570
52 WEEK LOW
0.3800
MARKET CAP
53.46M
P/E (TTM)
-3.4253
1D
5D
1M
3M
1Y
5Y
1D
Talphera Shareholders Approve Directors and Governance Proposals
TipRanks · 5d ago
Talphera shareholders approve amended 2020 equity incentive plan at annual meeting
PUBT · 5d ago
Weekly Report: what happened at TLPH last week (0615-0619)?
Weekly Report · 6d ago
Weekly Report: what happened at TLPH last week (0608-0612)?
Weekly Report · 06/15 09:06
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 06/08 17:06
Weekly Report: what happened at TLPH last week (0601-0605)?
Weekly Report · 06/08 09:06
Dollar Tree, Onto, Chipotle, Lululemon, Talphera Trending
TipRanks · 06/06 09:01
Talphera Price Target Announced at $3.00/Share by HC Wainwright & Co.
Dow Jones · 06/05 12:51
More
About TLPH
Talphera, Inc. is a specialty pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company’s portfolio consists of nafamostat product candidates and pre-filled syringe product candidates. The Company’s lead product candidate, Niyad, is a lyophilized formulation of nafamostat and is being studied under an investigational device exemption (IDE) as an anticoagulant for the extracorporeal circuit. Niyad is used in adult patients undergoing continuous renal replacement therapy (CRRT). LTX-608 is its nafamostat formulation for direct IV infusion being explored as an investigational product for one or more indications, including antiviral treatment, or treatment of acute respiratory distress syndrome (ARDS) disseminated intravascular coagulation (DIC), or acute pancreatitis. The Company’s two ready-to-use pre-filled syringe (PFS) product candidates include Fedsyra and phenylephrine.

Webull offers Talphera Inc stock information, including NASDAQ: TLPH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TLPH stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TLPH stock methods without spending real money on the virtual paper trading platform.